Skin of Color
New data shed light on the patient experience.
Curcumin, one of the active compounds of turmeric, exhibits anti-inflammatory, antimicrobial, antioxidant, anti-nociceptive, and antineoplastic properties.
Lori Kim, and Peter Lio, MD
New guidelines and new treatments seek to dramatically improve lives of
children with psoriasis.
Jennifer Soung, MD
Inside the approval of Zilxi for moderate-to-severe facial papulopustular rosacea.
Joshua Zeichner, MD
Exploring irritable bowel syndrome’s link to dermatologic conditions.
Marta Turowski, and Peter Lio, MD
While there’s no data about susceptibility to COVID-19 in psoriasis, there is relevant information on infectious complications from biologics.
Trifarotene is the first novel topical retinoid approved for the treatment of facial and truncal acne in 20 years.
Hypnosis has shown promising results for patients who have had difficulty responding to more conventional therapies.
Marta Turowski, and Peter A. Lio, MD
Is annual screening in all patients really neccesary?
Advances in formulation technology have led to the development of a stable topical minocycline that recently received FDA approval. Here’s what you should know.
Exploring the clinical implications of our current understanding of diet and eczema.
Sara Noor Bilimoria, and Peter A. Lio, MD
New method aims to improve access to systemic psoriasis therapy.
For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.
The psoriasis treatment landscape has changed dramatically during
this editor’s tenure.
Jerry Bagel, MD, FAAD
An update on lidose-isotretinoin and the ability to enhance absorption in the
absence of high-fat meals.
What do we really mean when we talk about flares or waxing and
Neha Chandan, MPH, and Peter A. Lio, MD
The newest IL-23 blocker for psoriasis may prove to be a blockbuster, according
A closer look at the first NCE approved to treat acne in more than a decade.
If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.
Jerry Bagel, MD
Stay up to date on all things Dermatology by signing up to recieve our print publication or subscribe to our email alerts.